Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 3/20 | 0.63 |
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | MGAM | O43451 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | SI | P14410 | 1/20 | 0.43 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.43 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.40 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.39 |
| ▸ | MMP8 | P22894 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL49875 | 0.97 | CYP4F2 (0.61) | CYP4F2CYP4A11ALDH1A1LMNAHSD17B10 | |
| SCHEMBL28872935 | 0.97 | CYP4F2 (0.61) | CYP4F2CYP4A11ALDH1A1LMNAHSD17B10 | |
| SCHEMBL11001997 | 0.97 | CYP4F2 (0.61) | CYP4F2CYP4A11ALDH1A1LMNAHSD17B10 | |
| Ammonia Solution, Strong SCHEMBL8176760 | 0.95 | CYP4F2 (0.59) | CYP4F2CYP4A11ALDH1A1LMNAHSD17B10 | |
| Bromide SCHEMBL25233680 | 0.95 | CYP4F2 (0.59) | CYP4F2CYP4A11ALDH1A1LMNAHSD17B10 | |
| Ethylenediamine SCHEMBL3498869 | 0.91 | CYP4F2 (0.55) | CYP4F2CYP4A11ALDH1A1LMNAHSD17B10 | |
| SCHEMBL504042 | 0.91 | CYP4F2 (0.55) | CYP4F2CYP4A11ALDH1A1LMNAHSD17B10 | |
| Trimethylammonium SCHEMBL27722697 | 0.91 | CYP4F2 (0.55) | CYP4F2CYP4A11ALDH1A1LMNAHSD17B10 | |
| SCHEMBL20512103 | 0.87 | CYP4F2 (0.62) | CYP4F2CYP4A11ALDH1A1LMNAHSD17B10 | |
| SCHEMBL5000137 | 0.87 | CYP4F2 (0.62) | CYP4F2CYP4A11ALDH1A1LMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 350 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115992021-A | Use of boron-containing additives as lead corrosion inhibitors | 卡斯特罗尔有限公司 | 2023-04-21 | — | — | CN | claimed |
| CN-110157413-B | Aggregation-induced emission molecular probe for selectively identifying lead ions and aluminum ions, and preparation method and application thereof | 浙江师范大学 | 2022-11-15 | — | — | CN | claimed |
| CN-113042344-A | Surface smoothing processing technology applied to natural stone processing | 邵阳市联合农林建材科技有限公司 | 2021-06-29 | — | — | CN | claimed |
| CN-112980005-A | Quasi-spherical particles and preparation method and application thereof | 中国科学院大连化学物理研究所 | 2021-06-18 | — | — | CN | claimed |
| CN-110358069-A | A kind of main chain polyester containing selenium and preparation method thereof | 浙江大学 | 2019-10-22 | — | — | CN | claimed |
| CN-109180937-A | A method of preparing aliphatic poly thioether | 浙江大学 | 2019-01-11 | — | — | CN | claimed |
| US-8529955-B2 | Methods of treatment using a gastric retained gabapentin dosage | DEPOMED, INC. (US) | 2013-09-10 | — | — | US | claimed |
| US-8475813-B2 | Methods of treatment using a gastric retained gabapentin dosage | DEPOMED, INC. (US) | 2013-07-02 | — | — | US | claimed |
| US-8440232-B2 | Methods of treatment using a gastric retained gabapentin dosage | DEPOMED, INC. (US) | 2013-05-14 | — | — | US | claimed |
| US-20120064168-A1 | METHODS OF TREATMENT USING A GASTRIC RETAINED GABEPENTIN DOSAGE | DEPOMED, INC. (US) | 2012-03-15 | — | — | US | claimed |
| WO-2003078045-A2 | MICROCAPILLARY HYBRIDIZATION CHAMBER | SYNGENTA PARTICIPATIONS AG (CH) | 2003-09-25 | — | — | WO | claimed |
| WO-1997043450-A1 | HYBRIDIZATION ASSAYS ON OLIGONUCLEOTIDE ARRAYS | AFFYMETRIX, INC. (US) | 1997-11-20 | — | — | WO | claimed |
| US-5362902-A | Diuretics and treatment of cardiovascular disorders | PFIZER INC. (US) | 1994-11-08 | — | — | US | claimed |
| EP-0342850-B1 | ENANTIOMERIC GLUTARAMIDE DIURETIC AGENTS | Pfizer Limited (GB) | 1992-05-20 | — | — | EP | claimed |
| EP-0274234-B1 | SPIRO-SUBSITUTED GLUTARAMIDE DIURETIC AGENTS | Pfizer Limited (GB) | 1991-09-11 | — | — | EP | claimed |
| US-5030654-A | Glutaramide diuretic agents | PFIZER INC. (US) | 1991-07-09 | — | — | US | claimed |
| WO-1991007378-A1 | CYCLOALKYL-SUBSTITUTED GLUTARAMIDE DIURETIC AGENTS | PFIZER LIMITED (GB) | 1991-05-30 | — | — | WO | claimed |
| EP-0343911-A2 | Cycloalkyl-substituted glutaramide diuretic agents | Pfizer Limited (GB) | 1989-11-29 | — | — | EP | claimed |
| EP-0342850-A1 | Enantiomeric glutaramide diuretic agents | Pfizer Limited (GB) | 1989-11-23 | — | — | EP | claimed |
| EP-0274234-A2 | Spiro-subsituted glutaramide diuretic agents | Pfizer Limited (GB) | 1988-07-13 | — | — | EP | claimed |